Anytime I see data that is a subset of the real data set, I have to wonder why they did that. Why not the average annual rate of price increases over all prescription drugs? Why only 227 of them?
Also, I disagree with this quote: "Only when a 46 percent discount was applied to a pricy Hepatitis C treatment, Harvoni, did it become a good health care value -- at about $40,000 per year."
That's patently untrue. Hell, CTAF (California technology assessment forum, which assessed drugs for MediCal) found that Harvoni, at it's full price of almost $90K was cost effective. The real problem is that it would cost too much to treat everyone.